Corcept Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Corcept Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Corcept Therapeutics Inc Strategy Report
- Understand Corcept Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Corcept Therapeutics Inc (Corcept) discovers, develops and commercializes drugs for the treatment of severe metabolic and psychiatric disorders. The company’s proprietary technology cortisol modulation, lead product Korlym and focused research and development are its major strengths, even as reliance on third parties is a cause for concern to the company. Product pipeline and market potential of pancreatic cancer and Alzheimer's disease provide growth opportunities to the company. However, intense competition, adherence to regulations and uncertain R&D outcomes could affect the business prospects of the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer